相关实验视频

Updated: Jan 10, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

[高血和与代谢相关的脂肪肝疾病:复杂的关系]

T A Deeva¹, S V Okovityy^2,3, Yu O Shulpekova¹

¹I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University), 119991, Moscow, Russian Federation.

Voprosy pitaniia

|November 20, 2025

概括

代谢相关的脂肪肝疾病 (MAFLD) 可以降低尿素循环酶活性,导致高氨血. 这种氨的积累有助于疾病的进展和多器官并发症,建议氨监测作为潜在的管理策略.

科学领域:

肝病学和代谢研究.
研究肝病进展的分子机制.
了解代谢功能障碍和多器官病理之间的联系.

背景情况:

与代谢相关的脂肪肝病 (MAFLD) 影响全球大约三分之一的成年人群.
MAFLD与甲素 (尿素) 循环酶活性降低有关,可能导致高氨血.
超血症对各种细胞和组织类型产生有害影响,导致疾病的严重程度.

研究的目的:

评估氨作为MAFLD进展中的病原性因素的作用.
调查高氨血症对MAFLD伴随性疾病发展的贡献.
探索管理MAFLD相关并发症的潜在治疗点.

主要方法:

从俄罗斯和国际数据库 (eLibrary,PubMed,Google Scholar) 的出版物进行系统审查.
使用的关键词包括"非酒精性脂肪性肝病"",代谢相关的脂肪性肝病"",氨"",超血"",尿素循环"和"素循环".
纳入标准侧重于将NAFLD/MAFLD与高氨血和多器官损伤联系在一起的研究.

主要成果:

在MAFLD中脂肪的积累可能会损害尿素循环酶的功能,导致高氨血.
升高的氨水平会触发生物化学过程,如亡,炎症和表观遗传修饰.
这些过程可以推动MAFLD从肥胖症发展为肥胖肝炎,纤维化,肝硬化和肝细胞癌.

结论:

在MAFLD中尿素循环酶活性降低,可能是由于表观遗传变化和细胞衰老,导致高氨血.
超血症会对多个器官 (肝脏,大脑,肌肉,心血管,免疫系统) 产生负面影响,加剧并发性病理.
监测氨水平和实施减少氨的策略可能有利于MAFLD管理和预防不良结果.

关键词:

氨; 超氨; 超氨; 非酒精性脂肪肝疾病; 代谢相关的脂肪肝疾病; 尿素循环; 鸟类循环; 表观遗传因素.

更多相关视频

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

相关概念视频

Overview of Lipid Metabolism

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

Urea Cycle

Urea Cycle

The urea cycle describes how liver cells convert ammonia to urea. Ammonia is a toxic waste product of protein catabolism. Land animals must convert ammonia into the less toxic urea which can be safely eliminated by the kidneys through urine. Marine animals excrete ammonia directly, and the surrounding water dilutes the ammonia to safe levels.

Overview of Carbohydrate Metabolism

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...

Inborn Errors of Metabolism

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...